Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $9.02 | 52-week high | $16.27 |
| Prev. close | $8.88 | 52-week low | $7.88 |
| Day low | $9.02 | Volume | 3,000 |
| Day high | $9.41 | Avg. volume | 2,592 |
| 50-day MA | $9.42 | Dividend yield | N/A |
| 200-day MA | $12.55 |
CNCR Stock Price Chart Interactive Chart >
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Range ETFs |
| Expense Ratio | 0.79% |
| Underlying Index | Range Cancer Therapeutics Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 7.04M |
| Net Asset Value (NAV) | $9.02 |
| Options? | Yes |
| Total Holdings | N/A |
CNCR Price Returns
| 1-mo | -8.43% |
| 3-mo | -18.41% |
| 6-mo | -35.85% |
| 1-year | -37.40% |
| 3-year | -36.83% |
| 5-year | -62.10% |
| YTD | -26.73% |
| 2024 | -8.61% |
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.24% |
| 2020 | 36.53% |